about
Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study.Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area.Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain).Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, SpainDirect medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database.Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007-2013 in Catalonia: a population-based study.Understanding the physical, social, and emotional experiences of people with uncontrolled Type 2 diabetes: a qualitative study.Epidemiology and clinical management of type 2 diabetes mellitus and associated comorbidities in Spain (e-Management study).Prevalence, clinical features and risk assessment of pre-diabetes in Spain: the prospective Mollerussa cohort study.Is diabetes mellitus correctly registered and classified in primary care? A population-based study in Catalonia, Spain.Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: A survey research.The impact of a programme to improve quality of care for people with type 2 diabetes on hard to reach groups: The GEDAPS study.Impact of implementing electronic clinical practice guidelines for the diagnosis, control and treatment of cardiovascular risk factors: A pre-post controlled study.[The evolution of quality care indicators of patients with type 2 diabetes in the Spanish primary care (1996-2007). The RedGEDAPS quality of care program].Trends in chronic complications of type 2 diabetic patients from Spanish primary health care centres (GEDAPS study): ten year-implementation of St. Vincent recommendations.Is quality of life different between diabetic and non-diabetic people? The importance of cardiovascular risks.Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.[Methodological aspects of integrated care pathways].Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.[Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society].Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society.Incidence of complications and mortality in a type 2 diabetes patient cohort study followed up from diagnosis in a primary healthcare centre.[Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society].[Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society].Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes durationInvestigar en diabetes desde una base de datos de atención primaria: la experiencia del Sistema de Información para el Desarrollo de la Investigación en Atención Primaria (SIDIAP)[New insulins][New perspectives for the treatment of diabetes mellitus][Cardiovascular disease prevalence in recent diagnosed type 2 diabetic patients][Adherence of Type 2 Diabetes Mellitus approach: Current situation and possible solutions]Prevalence and control of type 2 diabetes mellitus among primary care physicians in Spain. PRISMA StudyThe Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based StudyTherapeutic Inertia: Still a Long Way to Go That Cannot Be PostponedHigh levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS StudyPrevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional studyGlycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world settingHow Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area
P50
Q34307460-7DA5A784-E1FD-49BB-9CB4-97BD1E46EBF4Q34385492-EA422D94-2C81-484F-8E61-DB4740FFD9BBQ35841178-CACE6A02-F3FD-4E0C-B7DB-EE1C28316EF8Q36531654-C0821240-951A-4ED0-859A-EBCFE5E8537BQ36645367-F13EF118-EE50-42BB-B323-55DC1975312BQ37306507-D4C6A9CF-16E3-4124-BE51-83FFFF283FF6Q37320310-BB69E521-E6CC-4348-9670-264A48FBA998Q37355883-F7FAE097-4CCD-40D0-95E6-EE07C47F6036Q37413097-E8AAECFC-4AC3-43A2-A6BC-EED4CE0D5EEFQ38649206-CEBD0918-5385-4387-A9DC-88D7EF76DB37Q38671739-D2BEA572-8C24-46AC-AE4B-AAFE9F2226F3Q38950536-BE135A52-0BFC-457E-B831-38E7570835A7Q39219056-718F8522-E158-4B55-8E45-D5399522B0DBQ40219866-4A7677F8-7EA3-4BD7-9173-9CDC6D5949ADQ40287214-D0749596-85EC-4B46-8D7B-0FF4660EF22DQ43274399-0972A91F-5F78-4F3F-AA84-EA432F02CDC8Q43568626-8CA7BA2A-7C87-426E-8C3B-79621DE29B0CQ47155245-8AEA4D87-ED6D-4FDD-B329-71993E00778FQ47716792-343D9A35-9E45-4BAF-A831-128D1E54AA61Q47780799-BB13957F-82E7-4E17-995C-C6BC6E008BCDQ50213742-848AA0C7-39D9-4444-8CF5-ED5A6E30DDEBQ50271509-05D54996-D3C7-4FAE-8707-A1C2F63C464DQ50450376-B5BB3FD5-3104-4764-B5D0-358B07E4471BQ50454128-27682182-FC3E-4F2E-A6B8-DF21EADDC36BQ51158769-5CA4FCF9-05A4-40B7-8CC6-B949123E62B2Q51307056-B01CFB6E-E136-496B-A87E-36BEF185AEAFQ51308450-BA6BFD78-E881-4FEE-9D55-32724D92A734Q57524038-A1765716-B26F-45B4-9C9F-BD396B0EA9E9Q61890394-BC6EE3A8-B15F-42B0-A6A6-FF7940FC6D33Q80393866-6272F290-808A-4711-972A-82ABE735F093Q81599200-CA087365-BBF0-4D6F-8E70-0A4344710FD4Q83403965-AE6F607A-1915-4FCF-8C00-712EAAEE2F02Q87095280-BC05B536-F781-4BBE-AA9D-B2DC96A7E276Q88042541-255C6E0A-543B-4E45-A7EC-E954AC82CFEDQ89582068-C481471B-A87D-4BD2-B1E7-2360D8658B3AQ89963486-98F1E4CA-6118-4495-A8AF-CFF21E4D4B4AQ90178919-F57F22B9-6FF8-44DF-836F-A3962617B53DQ90990368-296CFC66-CC23-47DA-9D51-632351914B73Q91526197-5CDEB19E-54CA-4EF5-B01C-173E16DFF394Q91793602-3A96A889-C991-40F6-A0AE-2E2A1FC02D78
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Manel Mata-Cases
@ast
Manel Mata-Cases
@en
Manel Mata-Cases
@es
Manel Mata-Cases
@nl
Manel Mata-Cases
@sl
type
label
Manel Mata-Cases
@ast
Manel Mata-Cases
@en
Manel Mata-Cases
@es
Manel Mata-Cases
@nl
Manel Mata-Cases
@sl
prefLabel
Manel Mata-Cases
@ast
Manel Mata-Cases
@en
Manel Mata-Cases
@es
Manel Mata-Cases
@nl
Manel Mata-Cases
@sl
P106
P1153
6602173061
P21
P31
P496
0000-0003-3693-3622